The biotechnology sector is entering a dynamic growth phase, fueled by advances in gene therapy, AI-assisted drug discovery, and personalized medicine. Global biotech revenue is projected to grow from $1.55 trillion in 2024 to over $4.6 trillion by 2034, reflecting a surge in both investment and innovation. Venture funding is rebounding strongly, with billions pouring… Continue reading Discovering the Next Wave of Biotech Innovation (MDCX, RNXT, JSPR, LSB)
Mark MCKelvie
Discovering the Next Wave of Biotech Innovation (MDCX, RNXT, JSPR, LSB)
The biotechnology sector is entering a dynamic growth phase, fueled by advances in gene therapy, AI-assisted drug discovery, and personalized medicine. Global biotech revenue is projected to grow from $1.55 trillion in 2024 to over $4.6 trillion by 2034, reflecting a surge in both investment and innovation. Venture funding is rebounding strongly, with billions pouring… Continue reading Discovering the Next Wave of Biotech Innovation (MDCX, RNXT, JSPR, LSB)
Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)
The biotech sector is entering a pivotal phase fueled by scientific breakthroughs, accelerated regulatory approvals, and a surge of strategic dealmaking. The Nasdaq Biotechnology Index has posted strong gains, signaling renewed investor confidence. The FDA is clearing a record number of novel therapies, while global mergers and acquisitions have climbed past $105 billion, a seven… Continue reading Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)
Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market
The crucial role of vaccines in protecting public health couldn’t have been clearer than with the recent coronavirus pandemic. COVID-19 vaccines were instrumental in helping to reduce the spread of the virus, propelling vaccines to the top ten therapy category by sales as of 2023. At the height of the pandemic, Cominarty, which was jointly… Continue reading Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market
Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market
The crucial role of vaccines in protecting public health couldn’t have been clearer than with the recent coronavirus pandemic. COVID-19 vaccines were instrumental in helping to reduce the spread of the virus, propelling vaccines to the top ten therapy category by sales as of 2023. At the height of the pandemic, Cominarty, which was jointly… Continue reading Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market
Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA)
After years of uncertainty, biotech is bouncing back. The Nasdaq Biotechnology Index is up over 18% year-to-date, outpacing the broader health care sector. Growth is fueled by paused interest rate hikes, record FDA approvals, and a surge in M&A activity topping $75 billion in the first half of 2025. Large pharma companies facing patent expirations… Continue reading Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA)
Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA)
After years of uncertainty, biotech is bouncing back. The Nasdaq Biotechnology Index is up over 18% year-to-date, outpacing the broader health care sector. Growth is fueled by paused interest rate hikes, record FDA approvals, and a surge in M&A activity topping $75 billion in the first half of 2025. Large pharma companies facing patent expirations… Continue reading Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA)
The Drone Market Is Surging as Regulation and Defense Demand Accelerate ZenaTech’s Momentum
Over the past few months, the once-niche drone market has evolved into a compelling, investable secular story. Regulatory friction is giving way to clarity. On August 5, 2025, the U.S. Department of Transportation, alongside the FAA and TSA, unveiled a Notice of Proposed Rulemaking (NPRM) aimed at normalizing Beyond Visual Line of Sight (BVLOS) drone… Continue reading The Drone Market Is Surging as Regulation and Defense Demand Accelerate ZenaTech’s Momentum
The Drone Market Is Surging as Regulation and Defense Demand Accelerate ZenaTech’s Momentum
Over the past few months, the once-niche drone market has evolved into a compelling, investable secular story. Regulatory friction is giving way to clarity. On August 5, 2025, the U.S. Department of Transportation, alongside the FAA and TSA, unveiled a Notice of Proposed Rulemaking (NPRM) aimed at normalizing Beyond Visual Line of Sight (BVLOS) drone… Continue reading The Drone Market Is Surging as Regulation and Defense Demand Accelerate ZenaTech’s Momentum
U.S. Drone Stocks Ready for Liftoff with Groundbreaking FAA Proposal (ZENA, AVAV, KTOS, ONDS)
The race to dominate the drone economy has just entered a new phase. On August 6, 2025, U.S. Transportation Secretary Sean P. Duffy unveiled a sweeping proposal that could dramatically expand where and how drones operate in American skies. The new Beyond Visual Line of Sight (BVLOS) rule aims to remove one of the biggest… Continue reading U.S. Drone Stocks Ready for Liftoff with Groundbreaking FAA Proposal (ZENA, AVAV, KTOS, ONDS)